IP Verse

Rna Containing Composition For Treatment Of Tumor Diseases - EP3326641B1

PatentPatent Analysis

EP3326641

CUREVAC
Application Number
EP17196250A
Filing Date
Apr 22, 2016
Status
Revoked
Jun 27, 2024
Grant Date
Jun 26, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3283059B1
EP4155409B1
EP4108769B1

Bibliography

The patent EP3326641B1 was granted to Curevac on Jun 26, 2019 following the initial filing on Apr 22, 2016 under the application number EP17196250A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

FRIEDRICHApr 17, 2020WITHDRAWN
GRUNDMar 26, 2020ADMISSIBLE
PFIZERMar 26, 2020ADMISSIBLE
MERCK SHARP & DOHMEMar 24, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents